ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Rollins Stings as Analysts Cut Ratings and Targets

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Pest control giant ROL took the sharpest hit in Thursday's analyst activity. The consensus rating was downgraded as the average target price plunged from $55.29 to $47.94. That is a 13% cut. Rollins carries a $20.9 billion market cap and short interest sits at 4.6% of free float — modest, but worth watching if selling pressure builds.

WST received a new analyst recommendation. West Pharmaceutical Services drew fresh coverage with an average target of $394.62. The prior consensus sat at $384.29. The $25.3 billion drug delivery company now has 14 holds and one buy in its coverage mix.

AMD continued its slow-burn target price creep upward. The consensus target edged from $545.91 to $547.29. AMD now has 41 buy ratings against just 10 holds. Short interest is only 2.5% of free float. Bulls clearly dominate the Street.

Rail stocks also caught upgrades. Both NSC and UNP saw target price increases. Norfolk Southern's consensus target rose to $355.17. Union Pacific's moved to $319.57.

CMCSA was the other notable loser. The telecom giant's consensus target slipped from $30.85 to $30.65 amid three sell ratings in its coverage pool.

Stocks in this article

How this article was generated

Generated
24 Jul 2026, 08:20
Prompt version
v1.0
Data sources
Analyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.